81972726/National Natural Science Foundation of China[Grants and Funding] - Search Results

Year	Number of Results
2021	1
2022	2
2023	4
2024	3

1

Conversion therapy for advanced hepatocellular carcinoma in the era of precision medicine: Current status, challenges and opportunities.

Wang MD, Xu XJ, Wang KC, Diao YK, Xu JH, Gu LH, Yao LQ, Li C, Lv GY, Yang T. Wang MD, et al. Cancer Sci. 2024 May 2. doi: 10.1111/cas.16194. Online ahead of print. Cancer Sci. 2024. PMID: 38695305 Free article. Review.

2

Prognostic significance of nodular number in patients undergoing hepatectomy of intermediate-stage hepatocellular carcinoma.

Fan ZQ, Serenari M, Lv X, Schwartz M, Qiu W, Pawlik TM, Chen Z, Zhou YH, Wang XM, Chen TH, Li J, Zhang CW, Wang H, Zhang YM, Gu WM, Liang YJ, Diao YK, Yao LQ, Li C, Cescon M, Wang MD, Sun XD, Lau WY, Shen F, Yang T, Lv G. Fan ZQ, et al. Br J Surg. 2024 Mar 2;111(3):znae047. doi: 10.1093/bjs/znae047. Br J Surg. 2024. PMID: 38456676 No abstract available.

3

Hydrogel Crosslinked with Nanoparticles for Prevention of Surgical Hemorrhage and Recurrence of Hepatocellular Carcinoma.

Zhu JQ, Wu H, Li X, Li MY, Li ZL, Xu XF, Gu LH, Yin DX, Shen F, Huang DS, Yang T. Zhu JQ, et al. Adv Sci (Weinh). 2024 Mar;11(9):e2305508. doi: 10.1002/advs.202305508. Epub 2023 Dec 25. Adv Sci (Weinh). 2024. PMID: 38145957 Free PMC article.

4

Severe pleural effusion after hepatectomy for hepatocellular carcinoma: multicentre retrospective study.

Fan ZQ, Diao YK, Li C, Yao LQ, Zhang CW, Zeng YY, Chen ZX, Zhou YH, Gu WM, Wang H, Chen TH, Zhang YM, Xu X, Liang YJ, Wang XM, Zhang WG, Li J, Wang MD, Wu H, Xu XF, Pawlik TM, Lau WY, Shen F, Yang T, Lv GY. Fan ZQ, et al. BJS Open. 2023 Nov 1;7(6):zrad118. doi: 10.1093/bjsopen/zrad118. BJS Open. 2023. PMID: 38108467 Free PMC article. No abstract available.

5

Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences.

Yang T, Wang MD, Xu XF, Li C, Wu H, Shen F. Yang T, et al. Clin Mol Hepatol. 2023 Apr;29(2):342-344. doi: 10.3350/cmh.2023.0106. Epub 2023 Mar 16. Clin Mol Hepatol. 2023. PMID: 36924123 Free PMC article. No abstract available.

6

Mesoporous Nanoparticles for Diagnosis and Treatment of Liver Cancer in the Era of Precise Medicine.

Wu H, Wang MD, Zhu JQ, Li ZL, Wang WY, Gu LH, Shen F, Yang T. Wu H, et al. Pharmaceutics. 2022 Aug 23;14(9):1760. doi: 10.3390/pharmaceutics14091760. Pharmaceutics. 2022. PMID: 36145508 Free PMC article. Review.

7

Association of Concurrent Metabolic Syndrome with Long-term Oncological Prognosis Following Liver Resection for Hepatocellular Carcinoma Among Patients with Chronic Hepatitis B Virus Infection: A Multicenter Study of 1753 Patients.

Wang MD, Tang SC, Li C, Sun LY, Xu X, Liang YJ, Liu FB, Gu WM, Wang XM, Zhou YH, Lau WY, Zhang CW, Yao LQ, Diao YK, Gu LH, Shen F, Zeng YY, Yang T. Wang MD, et al. Ann Surg Oncol. 2023 Jan;30(1):346-358. doi: 10.1245/s10434-022-12529-6. Epub 2022 Sep 16. Ann Surg Oncol. 2023. PMID: 36114441

8

Fatty acid transport protein-5 (FATP5) deficiency enhances hepatocellular carcinoma progression and metastasis by reprogramming cellular energy metabolism and regulating the AMPK-mTOR signaling pathway.

Wang MD, Wang NY, Zhang HL, Sun LY, Xu QR, Liang L, Li C, Huang DS, Zhu H, Yang T. Wang MD, et al. Oncogenesis. 2021 Nov 12;10(11):74. doi: 10.1038/s41389-021-00364-5. Oncogenesis. 2021. PMID: 34772914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year